Disease | Systemic manifestations | Radiological features | Histopathology | Treatment |
---|---|---|---|---|
CNS-LyG | CNS and systemic involvement (i.e., lungs, skin, etc.), respiratory and focal neurological deficits. | Diffuse infiltrative lesions and mass-like lesions in the brain. Linear, patchy, nodular, mass-like, and irregular ring-like lesions on contrast-enhanced CT scans. | Polymorphous lymphoid cell infiltration, lymphocytic vasculitis, lymphocytic invasion of vascular walls, and granulomatous lesions. CD68 (+), CD3 (+), CD20 (+). | Surgery, observation, steroid hormones, interferon, chemotherapy, radiotherapy, rituximab, stem cell transplantation and bone marrow transplantation. |
CNS-ECD | CNS and systemic involvement (i.e., lungs, bone, etc.), bone pain, diabetes insipidus and cerebellar ataxia. | Occupying lesions or massive nodules in the brain, involving the dura and showing meningioma-like masses with obvious homogeneous enhancement. | Observation of lipid-rich foam cells or eosinophilic cytoplasmic histiocytes and fibroblasts. CD68 (+), CD1a (-), S-100 (+/-) and Birbeck granules (-). | Surgery, observation, steroid hormones, interferon, cytotoxic drugs, radiotherapy and targeted drugs. |
CNS-T-LYP | CNS and systemic involvement (i.e., lungs, joints, etc.). | Multiple occupying and diffuse lesions in the brain with punctate, mass-like, and ring-like enhancement; peripheral edema; involvement of both brainstem and cerebellum. | Diffuse infiltration of massive microlymphoidocytes, perivascular lymphoid sheaths, abundant reticular fibers, no obvious mitotic phase. CD3 (+), CD4 (+) and CD8 (+/-). | Surgery, steroid hormones and immunosuppressants. |
CNS-IgG4-RD | CNS and systemic involvement (i.e., pancreas, salivary lacrimal glands, kidneys, lungs, etc.). | Orbital pseudotumor, hypophysitis, diffuse thickening or masses in the endocranium/dura mater. | Massive lymphocyte and plasma cell infiltration with fibrosis, IgG-positive plasma cells > 40%. | Steroid hormones, rituximab, azathioprine and other immunosuppressants, imatinib and tocilizumab. |
CNS-RDD | Involvement of the CNS, enlargement of surrounding lymph nodes, visual changes, pituitary dysfunction and spinal cord dysfunction. | Multiple occupying, meningioma-like lesions in the brain and the spinal cord with obvious homogeneous enhancement and cystic degeneration, and involvement of the endocranium/dura mater. | Infiltration of various types of cells, massive Russell bodies and emperipolesis. S-100 (+), CD68 (+), CD163 (+) and CD1a (+). | Surgery, observation, steroid hormones, radiotherapy, cytotoxic drugs, rituximab and immunosuppressants. |